STK11 and cancer: If LKB1 mediates the cell growth-inhibitory activation of AMPK in response to metformin's alteration of de novo nucleotide pool maintenance, we would expect that LKB1-negative cancer cannot compensate for the growth-inhibitory effect of metformin when importing thymidine and/or hypoxanthine from the extracellular milieu.